Clinical Trial Update: Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase II clinical trial update comparing PG-102(MG12) with placebo in obesity and type 2 diabetes, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• PG-102(MG12) (MG12)

Snippet

Sponsor: ProGen. Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING